210 related articles for article (PubMed ID: 34126594)
1. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.
Zhao L; Han S; Hou J; Shi W; Zhao Y; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16341-16352. PubMed ID: 34126594
[TBL] [Abstract][Full Text] [Related]
2. MiR-27b-3p suppresses glioma development via targeting YAP1.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
Biochem Cell Biol; 2020 Aug; 98(4):466-473. PubMed ID: 32567955
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis.
Zhang Y; Ding L; Ni Q; Tao R; Qin J
Aging (Albany NY); 2021 Jun; 13(12):16786-16803. PubMed ID: 34162761
[TBL] [Abstract][Full Text] [Related]
4. MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10.
Yang X; Chen J; Liao Y; Huang L; Wen C; Lin M; Li W; Zhu Y; Wu X; Iwamoto A; Wang Z; Liu H
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763673
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
Zhang C; Zou Y; Dai DQ
Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
[TBL] [Abstract][Full Text] [Related]
6. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
9. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TUG1 exhibits pro-fibrosis activity in hypertrophic scar through TAK1/YAP/TAZ pathway via miR-27b-3p.
Li XM; Yu WY; Chen Q; Zhuang HR; Gao SY; Zhao TL
Mol Cell Biochem; 2021 Aug; 476(8):3009-3020. PubMed ID: 33791919
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
12. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
[TBL] [Abstract][Full Text] [Related]
13. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
14. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2.
Han M; Li N; Li F; Wang H; Ma L
Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118
[TBL] [Abstract][Full Text] [Related]
15. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.
Chen D; Si W; Shen J; Du C; Lou W; Bao C; Zheng H; Pan J; Zhong G; Xu L; Fu P; Fan W
Cell Death Dis; 2018 Feb; 9(2):188. PubMed ID: 29416005
[TBL] [Abstract][Full Text] [Related]
16. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
18. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
[TBL] [Abstract][Full Text] [Related]
19. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-876-5p represses the cell proliferation and invasion of colorectal cancer through suppressing YAP signalling via targeting RASAL2.
Ren L; Zhang Z; Feng Y; Luo M; Hao Z
Clin Exp Pharmacol Physiol; 2020 May; 47(5):867-876. PubMed ID: 31990059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
